Use of Maribavir for Multidrug-Resistant Cytomegalovirus in an Immunocompromised Host With HIV and Common Variable Immunodeficiency

We present a case of multidrug-resistant Cytomegalovirus (CMV) and the use of maribavir, a novel oral treatment of resistant CMV, in a nontransplant immunocompromised host. Our patient initially was diagnosed with CMV pharyngitis on biopsy. Although his initial CMV pharyngitis resolved, the CMV isol...

Full description

Saved in:
Bibliographic Details
Main Authors: Diana Zarowin, Jared Coe, Maxwell Bressman, Paul Riska, Philip Yune, Ghaleb Halaseh, Matthew J. Akiyama
Format: Article
Language:English
Published: American College of Physicians 2024-06-01
Series:Annals of Internal Medicine: Clinical Cases
Online Access:https://www.acpjournals.org/doi/10.7326/aimcc.2023.1153
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850202593095057408
author Diana Zarowin
Jared Coe
Maxwell Bressman
Paul Riska
Philip Yune
Ghaleb Halaseh
Matthew J. Akiyama
author_facet Diana Zarowin
Jared Coe
Maxwell Bressman
Paul Riska
Philip Yune
Ghaleb Halaseh
Matthew J. Akiyama
author_sort Diana Zarowin
collection DOAJ
description We present a case of multidrug-resistant Cytomegalovirus (CMV) and the use of maribavir, a novel oral treatment of resistant CMV, in a nontransplant immunocompromised host. Our patient initially was diagnosed with CMV pharyngitis on biopsy. Although his initial CMV pharyngitis resolved, the CMV isolated from blood became resistant to ganciclovir and cidofovir and eventually required treatment with foscarnet. Our patient was given a trial of maribavir. After 6 weeks, the patient's viremia resolved and remained undetectable for 6 months after treatment initiation with maribavir. This case demonstrates the feasibility of using maribavir for resistant CMV in a nontransplant, immunocompromised patient.
format Article
id doaj-art-d71c72c48de3425f80525e18cd271f36
institution OA Journals
issn 2767-7664
language English
publishDate 2024-06-01
publisher American College of Physicians
record_format Article
series Annals of Internal Medicine: Clinical Cases
spelling doaj-art-d71c72c48de3425f80525e18cd271f362025-08-20T02:11:45ZengAmerican College of PhysiciansAnnals of Internal Medicine: Clinical Cases2767-76642024-06-013610.7326/aimcc.2023.1153Use of Maribavir for Multidrug-Resistant Cytomegalovirus in an Immunocompromised Host With HIV and Common Variable ImmunodeficiencyDiana Zarowin0Jared Coe1Maxwell Bressman2Paul Riska3Philip Yune4Ghaleb Halaseh5Matthew J. Akiyama61Albert Einstein College of Medicine, Bronx, New York2Department of Medicine, Division of Infectious Diseases, Montefiore Medical Center, Bronx, New York3Department of Medicine, Division of General Internal Medicine, Montefiore Medical Center, Bronx, New York2Department of Medicine, Division of Infectious Diseases, Montefiore Medical Center, Bronx, New York2Department of Medicine, Division of Infectious Diseases, Montefiore Medical Center, Bronx, New York2Department of Medicine, Division of Infectious Diseases, Montefiore Medical Center, Bronx, New York1Albert Einstein College of Medicine, Bronx, New YorkWe present a case of multidrug-resistant Cytomegalovirus (CMV) and the use of maribavir, a novel oral treatment of resistant CMV, in a nontransplant immunocompromised host. Our patient initially was diagnosed with CMV pharyngitis on biopsy. Although his initial CMV pharyngitis resolved, the CMV isolated from blood became resistant to ganciclovir and cidofovir and eventually required treatment with foscarnet. Our patient was given a trial of maribavir. After 6 weeks, the patient's viremia resolved and remained undetectable for 6 months after treatment initiation with maribavir. This case demonstrates the feasibility of using maribavir for resistant CMV in a nontransplant, immunocompromised patient.https://www.acpjournals.org/doi/10.7326/aimcc.2023.1153
spellingShingle Diana Zarowin
Jared Coe
Maxwell Bressman
Paul Riska
Philip Yune
Ghaleb Halaseh
Matthew J. Akiyama
Use of Maribavir for Multidrug-Resistant Cytomegalovirus in an Immunocompromised Host With HIV and Common Variable Immunodeficiency
Annals of Internal Medicine: Clinical Cases
title Use of Maribavir for Multidrug-Resistant Cytomegalovirus in an Immunocompromised Host With HIV and Common Variable Immunodeficiency
title_full Use of Maribavir for Multidrug-Resistant Cytomegalovirus in an Immunocompromised Host With HIV and Common Variable Immunodeficiency
title_fullStr Use of Maribavir for Multidrug-Resistant Cytomegalovirus in an Immunocompromised Host With HIV and Common Variable Immunodeficiency
title_full_unstemmed Use of Maribavir for Multidrug-Resistant Cytomegalovirus in an Immunocompromised Host With HIV and Common Variable Immunodeficiency
title_short Use of Maribavir for Multidrug-Resistant Cytomegalovirus in an Immunocompromised Host With HIV and Common Variable Immunodeficiency
title_sort use of maribavir for multidrug resistant cytomegalovirus in an immunocompromised host with hiv and common variable immunodeficiency
url https://www.acpjournals.org/doi/10.7326/aimcc.2023.1153
work_keys_str_mv AT dianazarowin useofmaribavirformultidrugresistantcytomegalovirusinanimmunocompromisedhostwithhivandcommonvariableimmunodeficiency
AT jaredcoe useofmaribavirformultidrugresistantcytomegalovirusinanimmunocompromisedhostwithhivandcommonvariableimmunodeficiency
AT maxwellbressman useofmaribavirformultidrugresistantcytomegalovirusinanimmunocompromisedhostwithhivandcommonvariableimmunodeficiency
AT paulriska useofmaribavirformultidrugresistantcytomegalovirusinanimmunocompromisedhostwithhivandcommonvariableimmunodeficiency
AT philipyune useofmaribavirformultidrugresistantcytomegalovirusinanimmunocompromisedhostwithhivandcommonvariableimmunodeficiency
AT ghalebhalaseh useofmaribavirformultidrugresistantcytomegalovirusinanimmunocompromisedhostwithhivandcommonvariableimmunodeficiency
AT matthewjakiyama useofmaribavirformultidrugresistantcytomegalovirusinanimmunocompromisedhostwithhivandcommonvariableimmunodeficiency